We continue to work closely with our partner to enable a seamless ... immunologic comparisons to establish non-inferiority ...

Novavax, Inc., based in Gaithersburg, Maryland, is a global biotechnology company focused on developing and commercializing innovative protein-based vaccines to combat serious infectious diseases, ...

In a report released today, Brendan Smith from TD Cowen maintained a Hold rating on Novavax (NVAX – Research Report), with a price target ...

The candidate vaccines are part of Novavax's portfolio of recombinant protein-based vaccines ... the ID-UTI measure can be ...

China has reported seven more H9N2 avian flu infections in humans, mostly involving children and all in people whose symptoms ...

Novavax has made a smaller splash in the U.S. Covid-19 vaccine market than it had hoped. But it's betting on licensing deals ...

Novavax shares dropped Tuesday morning after the company slashed its full-year outlook when it announced its third-quarter results.

Novavax's COVID-19 vaccine continues to be its only commercial product and currently has about 2%-3% market share, according ...

More doctors are looking out for the condition. But that’s not enough to explain the increase in the nation’s overall ...

Novavax said the Food and Drug Administration allowed it to continue testing a combination COVID-19-flu and standalone flu vaccine that had been put on hold.